Summary
PhaseBio Pharmaceuticals
Founded in 2002
Description
PhaseBio is focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial focus on cardiopulmonary indications.
Strengths
- PhaseBio Pharmaceuticals has a strong market share in their industry
- Since PhaseBio Pharmaceuticals was founded, the company has grown faster than the industry average
Weaknesses
- Revenue generated per employee is less than the industry average
Annual Revenue
PhaseBio Pharmaceuticals's annual revenue
$10948000
Based on Kona Equity data
-
Revenue per employee
$182467
-
Annual revenue growth since founding
$547400
Employee Count
60 employees
Executives
Glen Burkhardt
Senior VP, Human Resources
g**@phasebio.comPhone Pharmaceuticals
Ph. D. Chief Executive Officer
p**@phasebio.comJonathan Mow
Chief Executive Officer
j**@phasebio.comJeffrey Erickson
Senior Director, Corporate Development
j**@phasebio.comSusan Arnold
Senior VP, Technical Operations
s**@phasebio.comWilliam Amerine
Global of Clinical Operations Head
w**@phasebio.comChristopher Prior
Ph. D. Chief Executive Officer
c**@phasebio.comGail Zanecosky
Controller
g**@phasebio.comJeffrey Glenn
Senior Director, Analytical Development
j**@phasebio.comJohn-Paul Lee
Chief Medical Officer
j**@phasebio.comMichael Reid
CMC Director, Quality Assurance
m**@phasebio.comLeonard Fasullo
Senior Director, Commercial Manufacturing Operations
l**@phasebio.comG Score - 2
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Visterra , Inc.
visterrainc.com- Founded in 2007
- Location: Waltham, Massachusetts
- Annual Revenue: $18.9M
- Employees: 53
- Visterra is a biologics research and early stage clinical development company developing therapies for patients with immune mediated and other hard to treat diseases. Our proprietary technology platform enables the design and engineering of precision a...
CymaBay Therapeutics
cymabay.com- Founded in 1990
- Location: Newark, CA
- Annual Revenue: $20.3M
- Employees: 59
- CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX...
Applied Therapeutics
appliedtherapeutics.com- Founded in 2016
- Location: New York City, NY
- Annual Revenue: $9.1M
- Employees: 27
- Applied Therapeutics is a clinical stage biopharmaceutical company that uses our novel drug development approach to create transformative, life changing treatments for the patients who desperately need them. Biotechnology Research
Madrigal Pharmaceuticals Inc
madrigalpharma.com- Founded in 2016
- Location: Conshohocken, PA
- Annual Revenue: $31.1M
- Employees: 92
- Madrigal Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with metabolic and fatty liver diseases, including nonalcoholic steatohepatitis (NASH).
Bellerophon Therapeutics, Inc.
bellerophon.com- Founded in 2014
- Location: Warren, NJ
- Annual Revenue: $6.8M
- Employees: 20
- Bellerophon Therapeutics is a clinical stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well studied molecules ...
Lyndra Inc
lyndra.com- Founded in 2015
- Location: Watertown, MA
- Annual Revenue: $5.2M
- Employees: 100
- Lyndra Therapeutics is a clinical stage biopharmaceutical company that is pioneering long acting oral therapies. Their LYNX drug delivery platform has the potential to transform virtually any oral therapy into weekly or monthly pills. They are focused...
Key Information
- Name: PhaseBio Pharmaceuticals
- Industry: Pharmacy
- SIC: 28; 283
- NAICS: 32; 325
See similar companies
-
By City Malvern Small Pharmacy in Malvern Mid-size Pharmacy in Malvern
-
By State PA Small companies in PA Small Pharmacy in PA Mid-size Pharmacy in PA
-
By Industry Pharmacy Small Pharmacy Mid-size Pharmacy
-
Firmographic data G Score of 2 Founded in 2002 SIC: 28 SIC: 283 NAICS: 32 NAICS: 325 #Manufacturing #Pharmaceuticals
Frequently Asked Questions
PhaseBio Pharmaceuticals's headquarters are located at 1 Great Valley Pkwy Ste 30 Malvern, PA 19355.
PhaseBio Pharmaceuticals's official website is phasebio.com
PhaseBio Pharmaceuticals's annual revenue is $10.9 M.
PhaseBio Pharmaceuticals's SIC: 28; 283
PhaseBio Pharmaceuticals's NAICS: 32; 325.
PhaseBio Pharmaceuticals has 60 employees
